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Objectives. The aims af ttds study were 1) to develop an in vitm 
t?+w system in which reporfusion mediated by ultrasound- 
nccekmitd tluombolyds could be rtudkd. and 2) to test wbetbz 
ultraswad-perekrated thmmbolysis could hasten repafusian in 
this system. 
Ba&wd. Ultrasound has been shown to increase tiuue 
plasm&&en activator (tPAHnduced tbrcmbotysk in vitm as 
awsszd by radiacttve fibrtwgen wkase from tab&d et& and in 
an atdmal In viva “WJCI. 
Merhcds. To test wktheC repliuskn is nmlerated, we Pm. 
sted cMrttctlve whnk hid clots In 80 in vitro 8ow syslem. Four 
eontml clots were expwed to ultrwnmd only without any thmm. 
brdytic a!3ent @mup 1). Siren clots lvere exposed to cadinuous 
infwkm of mcumbinsnl tiwe.tmc pluminogpll activatw rl-PA 
and mmbmizcd to either mnthwous wave uhmsmmd exposure at 
a frqumcy of 0.5 MHz and u1 tntenstty of 8 W/cm* (group 2) (K 
tow !&wmmd (group 3). Flow d&l to the cloi and the rate of 
rrkrseolAda*kkdfibriopmd~werr~~~oxof 
~p&uion “td thrcmbolysis, r~.pctively. Sunpko were ab- 
Controlled clinical trials have shown the etikacy of throm. 
bolytic therapy in reducing mortaliiy (I,2) and in preserving 
left vCW~CU~W function (z-5). BcCaUSc the amOunt Of mYO- 
cardial muscle loss is proportional to the duration of isch- 
emia (6-g). efforts are currently being directed to enhancing 
the rate of thmmbolysis by the use of adjuvant therapy (9). 
Ultrasound at low frequencies (20 kHzl and high intensi- 
ties accelerates clot disruption in vitro (10-13) and in a 
canine model using either pulsed (IO, 12) or continuous wave 
ultrasound. Such ultrasound was delivered by catheter di- 
rcctly to the clot, and no lyttc therapy was used. Other 
preliminary studies have shown that catheter-delivered ul- 
trasound can enhance thrombcdysis in vitro. using urokinase 
(14) and recombinant tissue-type plasminopn activator (rt- 
PA) (15). 
A qualitatively diierent approach has been taken by 
srch UrposuR (9.4 * 9.; 
1.5% in g.., :, p < 
betweengmups2snd3 
vs. t4.2 + 14.746, p 
bigbor atIer 15 mkl of tlkmwad expwlre (12.8 * 9.1% 
ultraseund.tw&d mp 2 vs. 4.0 l 3.9% in 
The maximal di&relee betwwo gswps 2 
25 min (26.7 + 13.1% vs. 1.24 2 3.7%. II < 
Conclusions. ContbtuouS wm &tint 0.5 MH7. mtd ntt 
intewitv of 8 W/cm2 accekrrdes rt.PA-iudwd ibmmwvsb aad 
Kudo (16). who delivered ultrasound at lower intensities and 
much higher frequencies noninvasively in an in viva sysiem 
in which rt-PA was used. We (In have shown that oltla- 
sound at simoar frequencies (I MHz) and intensities lower 
than those of rhc catheter-based ultrasound system (14,15) 
can accelerate thrombolysis mediated by rt-PA in an in vitro 
system of test tubes (17). Laoer et al. (16) showed that 
ultrasound can enhance rt-PA-induced thrombolysis in vitro 
and in viva although the enhancemen in the rabbi1 jugular 
vein thrombosis model was not statistically sign&rat. 
The aims of this study were I) to develop an in vitro Row 
system in which rcperfusion medialed by ultrasound- 
accelerated thrombalysis could be studied, and 2) to test 
whether ultrasound-accelerated thmmbnlysis could hasten 
repert’usion in this system. 
Clot prepamtieo. Human hbrinogen (Grade L, Helena 
Laboratories) was radiolabeled with iodine-125, using the 
iodogen technique (19). The labeled fibrinogen was 95% 
clottable. An aliquot of 5 !o 7 &srs of radiolabeled fib&- 
oger. was added to 500 pliters of the titrated fresh blood 
obtained from two normal volunteers. The total radioactivity 
of the blood was measured in a gamma counter. Fifty pliters 
bsakr mntaining plasma serves as a reservoir. Plasma 
condnuousty circulates by a roller pump in the tube system. 
One branch of the system is completely occluded by a 
md&kkd clot sitwed proximal IO a t.2 mm in diameter 
narrowing. Recombinant tissue-type plasminogen activator 
(tPA) is continuously infused immediately proximal to the 
clot. A Row probe measuresthe ratcofflow distal totheclot. 
The three untakted -I point in the direction of Row. 
of 2 mallliter calcium chloride was added and then trans- 
ferred to a conical polyethylene tube, which made pan of the 
tube system just proximal to the point of maximal narrowing 
(see Fig. 1 and flow system section beiow). Five units of 
bovine thrombin (Calbiochem Carp) dissolved in 20 @ters 
of buffer solution (see later) were added. Clots were left in a 
vertical position for I h at room temperature to pemtit 
retraction. 
Flow system. A closed circuit flow system was developed 
(Fig. I). The circuit was made of plastic tubes (Tygon, 
Norton Industrial Plastics). The two ends of the circuit were 
immersed in a beaker containing fresh-frozen plasma ob- 
tained through the American Red Cross (Rochester Region). 
The tube system had a bifurcation to two parallel branches. 
A polyethylene conical tube (Fisher Scientific) in which the 
clot was formed was part of one of the two branches. The tip 
of the polyethylene tube was connected to a plastic connec- 
tor with an internal diameter of 1.2 mm that formed the 
narrowest oat of the circuit. An in-line ultrasound flow 
probe cont&ted to a Bow meter (Transanic Systems) was 
located just distal to the point of maximal narrowing. The 
Row probe resolution was 0.1 mUmin and it was calibrated 
for blood at 37’C. The II-PA was contittuously injected from 
a side ann, just proximal to the clot. A roller pump (Master- 
Rex) operated at a constant velocity provided Row in the 
systerll. 
Ultrasound. Clots were located at the focus of the ultra- 
sound field in a tank containing distilled water at 37°C. The 
source of ultrasound was a flat, 2.54-cm diameter, cylindric 
piezoekctric transducerdrivenat0.5 MHz in the continuous 
wave mode. A 3.cm thick block of rubber ws used as an 
acoustic absorber behind the clot to limit ultrasound reflec- 
tion and standing waves. The clots were placed 5.2 cm from 
the source of ultrasound where the 3.dB ultrasound beam 
width was 6 mm. The spatial peak intensity at the focus was 
8 W/cm*, measured by a needle-type hydropbone with a 
LO-mm activeelement (model NP-IWO. NTR Systems) that 
was calibrated against a spheric steel radiometer (20). Trans- 
mission loss through the polyethylene tube that housed the 
clot was 0.1 dB at 0.5 MHz. 
Four clots were exposed to ultrasound only without any 
thrombolytic agent (group I). Other clots had continuous 
infusion of r&PA immediately proximal to them, and were 
randomized to either ultrasound w.pos”re (group 2) or to no 
ultrasound (group 3). Except for group 1 studies. the oper- 
ator who handled the sampling and analysis did not know 
whether the ultrasound system was in use until after the data 
analysis had been completed. 
Bxpaimental protnwl. Retracted fresh whole blood clots 
were put in one branch of a flow system that was filled with 
200.ml heparinized (I U/ml) fresh-frozen plasma (heparin 
from Riker Lab., Inc.). Flow was continuously monitored, 
and tlow readings were obtained every 5 min for 2 h. At the 
end of the experiment he residual clot was removed and the 
maximal Row measured. Flow readings were expressed as a 
percent of maximal flow. Experiments with an initial @we 
n-PA infusion) flow reading of 25% of maximal Row were 
excluded from analysis because full obstruction was not 
obtained. Two milligrams of rt-PA (Genentech) was dis- 
solved in M ml of buffer wlmion. An initial bolus of 3 ml of 
the rt-PA solution (0.2 mg) was injected at aconstant rate for 
3 min; then 1.8 mg was continuously iqiected at a constant 
rate of 0.02 m&in (0.3 mUmin) for 90 min. Injection was 
performed “sing a Harvard Apparatus infusion pump. 
Plasma samoles of 200 uliter were obtained from the beaker 
every 5 oin for measurements of radioactivity. Because 
mixing of the labeled fibrin products in the beaker was 
homogeneous, this procedure provides data needed to ana- 
lyze the rate of thrombolysis, which is related to the rate of 
radioactive fibrin release from the clot. Therefore, the re- 
covery of labeled fibrin products in this system is Row 
dependent. Samples were obtained as duplicates. and the 
mean radioactive reading of the two samples was “red for 
ar._wis. Assuming a volume of distribution of 210 ml, the 
radiolabeled fibrin counting was calculated to percent of clot 
lysis. when the initia’ wunting of the lahelrd blood served as 
109%. 
The initial length of the clot was 2.5 to 3 cm. which is 
longer than the focal zone of the ultrasound beam. Therefore 
the proximal two thirds of the clot (the side nearest he n-PA 
infusion site) was moved along the ultrasound beam several 
times during the ultrasound exposure. as the proximal par- 
lion dissolved. However. the distal portion of the clnt was 
not exposed to the ultrasound beam. 
II-PA, tihrinogen and plasminogett measurements. Sam- 
ples of I ml of fresh-frozen plasma were collected at base- 
line, after 15 mitt and at the end of the experiments for 
plasminogen and fibrinogen measurements. Samples of 
203 #liter for t-PA antigen concentration measurements 
were obtained at baseline, immediately after bolus injection 
and at IS, 60.96 min and at the end of the experiments. All 
samples were collected in duplicate. The samples were kept 
frozen at -20°C and were analyzed together at the cod of the 
experiments. 
Fibrinogen was measured using a modification of the 
method of Von Claws (21). Plasminogen was assayed using 
the end point method (22). Values are expressed as percent 
of the concentration in pooled normal plasma. The t-PA 
antigen concentration was determined using an ELISA (Imu- 
bind-S, American Diagnostica Inc.). 
The results of the hematologic tests were expressed as 
mea” value e I SD. 
Microscopic an&is. At the end of the experiments. 
samples were withdraw from the beaker and observed 
under a light microscope (Bausch & Lomb) at a high power 
field (x4W) for particulate size analysis and to chaacterire 
debris shape ani composition. PIas& was examined for the 
presence of fibrin fragments, clusters of red blood cells and 
red blood cell morphology. Particles were measured usina a 
calibrated eyepieck mic&eter and hemocytometer. 
Statirttud anatwts. The mean value f SD of the percent 
clot lysis and thewpercent maximal Row rate were calculated 
at each time interval and results are reported as man value 
+ I SD. The statistical difference among means of the three 
groups was calculated using one-factor&.lysis of variance 
IANOVA). The statistical difference between means ofeach 
pair of treatments. at S-min time intervals, was tested using 
a two-tailed Student t test ior unpaired data with adjustment 
made using the Bonfermni correction. Ditferences were 
considered significant at p < 0.05 
Flow and ctut t@s. Reperfusiw did not ocwr (Pii. 2) and 
clot lysis app&imated zero (Fig. 3) in four exp&ents 
using ultrasound without rt-PA femur, I). Rewrfusion was 
obt&d in I4 of the 16 exp&m&s us& rt-FA and 
randomized to either ultrasound (group 2) or no ultrasound 
(group 3). In one experiment in each group no reperfusion 
Figure 3. Percent clot tysis (mean Yelue t t SD, platted 2 80 
against time. Group I (tigk control ultrasound 9 M 
only, no recombinant tissue-type plasminogen activator $ *D 
lrt-PA],, group 2 (qunra: ultrasound and “-PA), and 3 
gnu* 3 (ctmla: tt-PA only. no “lrras0”“d,. 
3. 
a20 
occurred and clot ivsis as measured bv measurements of 
radiolabeled fibrin &docts in the beak& was near zero. 
Continuous wave ultrasound at 8 Wlcm2enbanced tbrom- 
bolysis by rt-PA as measured either by flow or by direct 
measorement of clot lysis in vitro using release of radio- 
labeled fibrin. A trend toward ultrasound-enhanced clot Iysis 
(Fig. 3) was noted after 10 min (4.9 f 3.3% in group 2 vs. 
2.2 + 2.0% in group 3). After 15 min this reached statistical 
significance (12.8 ? 9.1% in group 2 vs. 4.0 + 3.9% in gmop 
3, p < 0.05). The maximal statistical significance was ob- 
tainedat 2S min(26.7? 13.1% ingroup2vs. 7.24 r 5.7%in 
group 3. p < 0.004). Restoration of flow (Fig. 2) was 
significantly earlier and the flow was significantly higher 
after 10 min in group 2 (with ultrasound exposure) than in 
auoup 3 (9.4 i 9.9% vs. 0.5 t 1.5% of maximal flow, p < 
0.05). 
Ultrasound exposure resulted in a marked shortening of 
the time interval rewired to exceed >50% of maximal flow 
(Fig. 2): 61.0 2 N&of maximal flow was achieved after 
25 min of ultrasound exposure in group 2 compared with 
58.8 + 38.7% after 50 min of rt-PA infusion to the now.- 
posed clots of group 3. Ultrasound exposure also shortened 
the time to obtain at least 50% of clot lysis (Fig. 3): 54 * 
22.7% of clot lyris was obtained after 60 min of exposure to 
ultrasound in -group 2 compared with 90 min bf rt-PA 
infusion required to achieve 51.3 2 24.5% of clot lysis in the 
nonexposed clots of group 3. 
The mean percent clot lysis was higher in group 2 (with 
ultrasound) than in group 3. This difference was statistically 
sig~ilicant for up to 45 min. when 49.4 ? 22.0% of the clot 
was lysed in group 2 compared with 24.0 + 14.3% in group 
3 (p < 0.04). 
At 55 min, the mean flow rate of group 2 was lower than 
that in group 3 (53.8 + 44.4 vs. 61.2 + 39.9% of maximal 
flow, p = 0.63). This is illustrated as a dip in the oppercutve 
in Fiaure 2. This difference lasted for 20 min. when the mean 
tlowiates almost equalized in both systems. Visual obser- 
vation made in the transparent tube system showed that in 
three experiments with ultrasound and in one without ultra- 
sound, a small portion of clot was detached from its distal 
end, which was not exposed to ultrasound, and advanced 
into the narrowest uart of the circuit, caosillg rcocclosion. 
This remnant was t&lly Iysed by the contiru&s infusion of 
rt-PA, causina restoration of l-low within I5 to 20 min. 
ISPA, fib&en and plasminogtn measurements. Table I 
represents the mean concentration of plasminogen and fi- 
brinogen achieved during six of the experiments in which 
R-PA was infused. These levels were si$niticaotly reduced 
from the baseline concentration as the r&PA infusion oro- 
ceeded. The tPA antigen concentration increased with con- 
tinuous drug infusion and no clearance. 
Mierosmpic aaalys& To determine if the clot was dis- 
rupted into large fragments by ultrasound, the plasma in the 
beaker reservoir was carefully observed at the end of most 
experiments. No macmscopic fragments could be seen. 
Samples taken from the beaker after two experiments were 
also observed by light microscopy. No clot fragments, 
clusters of red blood cells or fibrin fragments could be seen, 
and the red blood cell morphology was normal. 
Discussion 
This study demonstrates that 0.5~MHz continuous wave 
ultrasound et a peak intensity of 6 W/cm2 accelerates throm- 
bolysis of fresh whale blwd clots induced by rt-PA. The 
ultrasound effect was obtained rapidly, and a significant 
acceleration of thrombolvsis was observed at I5 min bv both 
restoration of Row and by radiolabeled fibrin prodoci mea- 
surements. This signific&t enhancement of tbrombolysis 
was sustained for 35 to 45 min in this experimental model. 
The e&t of ultrasound descriid in this report diiers 
from that in several oreviooslv reoorted studies ~10.12.131 in 
which ultrasound x&s delivered by catheter at much lower 
frequencies (20 kHz) and at higher intensities. Therefore, 
ultrasound catheter systems create violent cavitation and 
local large amplitude stitiog, producing fragments of vati- 
able size. Such an irvarive procedure was applied in viva in 
a canine model of femoral artery or vein thrombosis 
(10,12,23,24). Using anoncatheterapproach. Rosenrcheinet 
al. (25) reported thrombus ablation using shock waves of 
high powe; acoustic energy. A potential &planation for the 
lack of effect of ul~rasoond alone in the current experiment 
compared with that in these prior studies is that the oltra- 
sound in the torrent study was of higher frequency and 
lower intensity. 
The clots in the present study were 2.5 to 3 cm long. This 
dimension was several times the ultrasound beam widlh of 
6 mm at the focus, where the clots were exposed. It is 
potentially important that ultrasound exposure of only pa.lt 
of the full lhrornbus can result in accelerated tbrombolysis 
and reperfusion. The taost distal portion of the cl01 was 
separated from the pan of infusion of the lyric drug by the 
long c-101 interposed between them. 
One might ubservc that the initial benefit obtained by 
enhancement of clot lysis was not sustained, and the carves 
of the two treatment groops plotted against time actually 
converged after about 80 min. This tinding could be ex- 
plained by the lack of drug cIezrznce in th:: in vi!ro ,y:!em. 
Thus. the drug reached a very high concentration and 
eventually induced complete lysis. No difference could be 
observed between the w/o treatment groups after 85 to 
90 rnin, because all clots were enbrelg lysed and the robing 
reperfused. 
Ultrasound can cause biologic effects through several 
mechanisms (X.27) such as heating. ocou~tic cavitatmn a d 
microstreaming. We speculate that the mechanism of ubra- 
sound enboncement of thrombolysis may be enhancemelt of 
transport of the lytic agent to the clot by an acxstic effect 
not yet understood: however. it was the purpose of thip 
study to investigate efticacy nther than 10 determme mech- 
anism. 
Limitations of the smdy. Although plasminogcn and ii- 
brinogen concentrations and IPA antigenicity were found to 
be consistent with those observed during fibrinolytic therapy 
in viva. an in vitro system does .wt entirely mimic in viva 
thrombolysis and repelfusion in 211 its complexities. includ- 
ing clotting and thrombolytic physiology as well as vwcular 
anatomy, physiology and ultraound exposure variables. 
However, we believed that the simplified system described 
in this study might be useful to stidy et&y and variour 
relevant ultrasound exposure variables. 
The assay for fibrinolysis. measorement of soluble radio- 
labeled products in the beaker reservoir, was Row depen- 
dent. Partial clot lvsis could occur without aooexance of the 
fibrin degradation~products in the beaker iii fully obstroc- 
tive clot was present. Thus, clot lysis appeared to increase 
approximatel:~ 5 min after the improvement in Row. How- 
ever. total obstruction did not remain throughout the major- 
ity of experiments. Reperfusion was obtained in seven of 
eight experiments in group 2 (with ultrasound) and in seven 
of eight experiments in group 3 (wilhout ultrasound) but in 
nooe of the group 1 control experiments without rt-PA. 
Cawluslom. We conclude that ultrasound can accelernte 
at-PA-induced lhrombolysis and reperfusion in vitro. 
